This CTD dossier owner and manufacturer is a prominent player in the pharmaceutical industry, specializing in both human and animal health products. Their diverse portfolio includes branded generics, biologics, injectables, personal hygiene items, and consumer products. They boast a state-of-the-art GMP-compliant facility and have established subsidiaries to focus on specific areas like carbapenem injectables and consumer goods. The company is recognized for its commitment to quality, evidenced by certifications such as ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. They have a strong presence in regions like the EU, North America, Asia, and the Middle East. Key therapeutic areas include infectious diseases and mental health, with principal dosage forms encompassing oral solutions, tablets, injectables, and topical creams. The company actively invests in research and development to bring innovative products to market.